EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case report of a highly unusual phenomenon

Neha Seth, Phyu Thin Naing, Ram Singh, Saroja Geetha, Kalpana Reddy, Xinmin Zhang, Tianyu Yang, Jessica Caro, Wayne Tam

Pathobiology · 2025

DOI: 10.1159/000546669 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathobiology, 2025. Verfasst von Neha Seth und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Histiocytic Sarcoma, Cell Transdifferentiation. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Transdifferentiation of multiple myeloma (MM) into histiocytic sarcoma (HS) is exceptionally rare. We report a unique case, confirming this phenomenon through cytogenetics and molecular analyses. Case Presentation A 46-year-old woman with high-risk light chain MM developed extramedullary disease despite multiple lines of therapy. Biopsies revealed atypical histiocytic proliferation consistent with HS. Shared immunoglobulin gene rearrangements, cytogenetic alterations, and gene mutations, including a rare BRAF L485F, confirmed clonal relatedness between the two neoplasms. IGH::MAF translocation specific to MM and IGVH somatic hypermutation in HS suggests divergent evolution from a putative germinal center B-cell (GCB) precursor.

Conclusions

This case highlights lineage plasticity of MM to undergo HS transdifferentiation, potentially mediated through a mutated common GCB precursor antecedent to the plasma cell stage, and the subsequent development of HS and MM through acquisition of additional genetic events. Recognition of this exceptional phenomenon and understanding its underlying mechanism have implications for diagnosis, classification, and personalized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHistiocytic SarcomaCell TransdifferentiationHumansFemaleMiddle AgedMutation

Stichwörter der Autor:innen

BRAF L485F mutationDivergent evolutionHistiocytic sarcomaLineage plasticityMultiple myelomaTransdifferentiation

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, USA.
  • Department of Hematology/Oncology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, New York, USA.
  • Northwell Cytogenetics Laboratories, Zucker School of Medicine at Hofstra/Northwell, Northshore University Hospital, Manhasset, New York, USA.
  • Neogenomics Laboratories, Inc., Fort Myers, Florida, USA.
  • Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, USA, wtam2@northwell.edu.

Zitieren

APA

Seth, N., Naing, P. T., Singh, R., Geetha, S., Reddy, K., Zhang, X., Yang, T., Caro, J., & Tam, W. (2025). Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case report of a highly unusual phenomenon. Pathobiology. https://doi.org/10.1159/000546669

Vancouver

Seth N, Naing PT, Singh R, Geetha S, Reddy K, Zhang X, et al. Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case report of a highly unusual phenomenon. Pathobiology. 2025. doi:10.1159/000546669

BibTeX
@article{Seth2025,
  author = {Seth, Neha and Naing, Phyu Thin and Singh, Ram and Geetha, Saroja and Reddy, Kalpana and Zhang, Xinmin and Yang, Tianyu and Caro, Jessica and Tam, Wayne},
  title = {Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case report of a highly unusual phenomenon},
  journal = {Pathobiology},
  year = {2025},
  doi = {10.1159/000546669}
}
Kostenlos starten →